| CAR-TCR 2020 Cell & Gene Therapy Innovation Summit October 15-16, 2020 | Intercontinental Shanghai Pudong Jinjiang Tomson Hotel Organizer: DeeYee Consulting / Deliver Life Sciences
Supported by: the Society of Chinese Medicine of Greater @(SAPA-GP)
@ (BayHelix) 350+ from government regulatory agencies, industry associations, research universities, clinical research centers, large multinational pharmaceutical companies, innovative biotechnology companies, CAR-T, TCR-T, CAR-NK, TIL, AAV-based Gene Therapy cell and gene therapy immunotherapy developers, drug discovery and development equipment platforms, cell and Gene therapy services companies, pharmaceutical R&D services companies, clinical trial research organizations, artificial intelligence and solution providers, law firms, investment and consulting organizations, and other drug development leaders and senior representatives will discuss.
The road to commercialization and industrialization of cell and gene therapy -Consideration of the CAR-T manufacturing process and the establishment of controls and release methods.
-Current status of the development of AAV gene therapy products for rare diseases in China
-Development of Novel Cell Therapy Product for Neo-Coronary Pneumonia COVID-19
-Clinical Development and Update on CAR-T/TCR-T/CAR-NK Cell Therapy Products |
